Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,282,490
-$538,903 QoQ
Shares Held
490,331
-0.2% QoQ
Ownership
0.598%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. LXEO ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,282,490 490,331
2026-03-31 $2,821,393 491,532
2025-12-31 $1,591,658 160,288
2025-09-30 $187,771 28,279
2025-06-30 $107,144 26,653
2025-03-31 $75,540 21,770
2024-12-31 $199,873 30,376
2024-09-30 $350,615 38,785
2024-06-30 $235,001 14,651
2024-03-31 $82,648 5,271
2023-12-31 $109,077 8,128